Authors:
Razani, B
Engelman, JA
Wang, XB
Schubert, W
Zhang, XL
Marks, CB
Macaluso, F
Russell, RG
Li, MM
Pestell, RG
Di Vizio, D
Hou, H
Kneitz, B
Lagaud, G
Christ, GJ
Edelmann, W
Lisanti, MP
Citation: B. Razani et al., Caveolin-1 null mice axe viable but show evidence of hyperproliferative and vascular abnormalities, J BIOL CHEM, 276(41), 2001, pp. 38121-38138
Authors:
Lee, H
Woodman, SE
Engelman, JA
Volonte, D
Galbiati, F
Kaufman, HL
Lublin, DM
Lisanti, MP
Citation: H. Lee et al., Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase - Targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (Tyr-14), J BIOL CHEM, 276(37), 2001, pp. 35150-35158
Authors:
Galbiati, F
Engelman, JA
Volonte, D
Zhang, XL
Minetti, C
Li, MM
Hou, H
Kneitz, B
Edelmann, W
Lisanti, MP
Citation: F. Galbiati et al., Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities, J BIOL CHEM, 276(24), 2001, pp. 21425-21433
Authors:
O'Hagan, RC
Schreiber-Agus, N
Chen, K
David, G
Engelman, JA
Schwab, R
Alland, L
Thomson, C
Ronning, DR
Sacchettini, JC
Meltzer, P
DePinho, RA
Citation: Rc. O'Hagan et al., Gene-target recognition among members of the Myc superfamily and implications for oncogenesis, NAT GENET, 24(2), 2000, pp. 113-119
Authors:
Engelman, JA
Berg, AH
Lewis, RY
Lisanti, MP
Scherer, PE
Citation: Ja. Engelman et al., Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes, MOL ENDOCR, 14(10), 2000, pp. 1557-1569
Authors:
Lahoz, EG
Liegeois, NJ
Zhang, PM
Engelman, JA
Horner, J
Silverman, A
Burde, R
Roussel, MF
Sherr, CJ
Elledge, SJ
DePinho, RA
Citation: Eg. Lahoz et al., Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: Cooperativeinteractions in vivo, MOL CELL B, 19(1), 1999, pp. 353-363
Authors:
Galbiati, F
Volonte, D
Engelman, JA
Scherer, PE
Lisanti, MP
Citation: F. Galbiati et al., Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts - Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation, J BIOL CHEM, 274(42), 1999, pp. 30315-30321
Authors:
Parolini, I
Sargiacomo, M
Galbiati, F
Rizzo, G
Grignani, F
Engelman, JA
Okamoto, T
Ikezu, T
Scherer, PE
Mora, R
Rodriguez-Boulan, E
Peschle, C
Lisanti, MP
Citation: I. Parolini et al., Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane - Retention of caveolin-2 at the level of the Golgi complex, J BIOL CHEM, 274(36), 1999, pp. 25718-25725
Citation: Ja. Engelman et al., Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1) - Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines, FEBS LETTER, 448(2-3), 1999, pp. 221-230
Authors:
Galbiati, F
Volonte, D
Engelman, JA
Watanabe, G
Burk, R
Pestell, RG
Lisanti, MP
Citation: F. Galbiati et al., Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade, EMBO J, 17(22), 1998, pp. 6633-6648
Authors:
Engelman, JA
Zhang, XL
Galbiati, F
Volonte, D
Sotgia, F
Pestell, RG
Minetti, C
Scherer, PE
Okamoto, T
Lisanti, MP
Citation: Ja. Engelman et al., Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy, AM J HU GEN, 63(6), 1998, pp. 1578-1587